Plain English summary not yet available
The full original text is available below. Check back soon as we process this bill.
I
116TH CONGRESS
1ST SESSION
H. R. 127
To extend the principle of federalism to State drug policy, provide access
to medical marijuana, and enable research into the medicinal properties
of marijuana.
IN THE HOUSE OF REPRESENTATIVES
JANUARY 3, 2019
Mr. COHEN (for himself and Mr. YOUNG) introduced the following bill; which
was referred to the Committee on Energy and Commerce, and in addition
to the Committees on the Judiciary, and Veterans’ Affairs, for a period
to be subsequently determined by the Speaker, in each case for consider-
ation of such provisions as fall within the jurisdiction of the committee
concerned
A BILL
To extend the principle of federalism to State drug policy,
provide access to medical marijuana, and enable research
into the medicinal properties of marijuana.
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled,
2
SECTION 1. SHORT TITLE.
3
This Act may be cited as the ‘‘Compassionate Access,
4
Research Expansion, and Respect States Act of 2019’’ or
5
the ‘‘CARERS Act of 2019’’.
6
VerDate Sep 11 2014
23:02 Jan 14, 2019
Jkt 089200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H127.IH
H127
kjohnson on DSK79L0C42 with BILLS
2
•HR 127 IH
SEC. 2. FEDERALISM IN DRUG POLICY.
1
Section 708 of the Controlled Substances Act (21
2
U.S.C. 903) is amended—
3
(1) by striking ‘‘No provision’’ and inserting
4
the following:
5
‘‘(a) IN GENERAL.—Except as provided in subsection
6
(b), no provision’’; and
7
(2) by adding at the end the following:
8
‘‘(b) COMPLIANCE WITH STATE LAW.—Notwith-
9
standing any other provision of law, the provisions of this
10
title relating to marihuana shall not apply to any person
11
acting in compliance with State law, as determined by the
12
State, relating to the production, possession, distribution,
13
dispensation, administration, laboratory testing, recom-
14
mending use, or delivery of medical marihuana.’’.
15
SEC. 3. EXCLUSION OF CANNABIDIOL FROM DEFINITION OF
16
MARIHUANA.
17
Section 102 of the Controlled Substances Act (21
18
U.S.C. 802) is amended—
19
(1) in paragraph (16)—
20
(A) by striking ‘‘or cake, or the sterilized’’
21
and inserting ‘‘cake, the sterilized’’; and
22
(B) by adding ‘‘, or cannabidiol’’ before
23
the period at the end; and
24
(2) by adding at the end the following:
25
VerDate Sep 11 2014
23:02 Jan 14, 2019
Jkt 089200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H127.IH
H127
kjohnson on DSK79L0C42 with BILLS
3
•HR 127 IH
‘‘(57) The term ‘cannabidiol’ means the sub-
1
stance cannabidiol, as derived from marihuana or
2
the synthetic formulation, that contains not greater
3
than 0.3 percent delta-9-tetrahydrocannabinol on a
4
dry weight basis.’’.
5
SEC. 4. CANNABIDIOL DETERMINATION BY STATES.
6
Section 201 of the Controlled Substances Act (21
7
U.S.C. 811) is amended by adding at the end the fol-
8
lowing:
9
‘‘(k) CANNABIDIOL DETERMINATION.—If a person
10
grows or processes marihuana for purposes of making
11
cannabidiol in accordance with State law, the marihuana
12
shall be deemed to meet the concentration limitation under
13
section 102(57), unless the Attorney General determines
14
that the State law is not reasonably calculated to comply
15
with section 102(57).’’.
16
SEC. 5. RESEARCH.
17
(a) IN GENERAL.—Not later than 180 days after the
18
date of enactment of this Act, the Secretary of Health and
19
Human Services shall terminate the Public Health Service
20
interdisciplinary review process described in the guidance
21
entitled ‘‘Guidance on Procedures for the Provision of
22
Marijuana for Medical Research’’ (issued on May 21,
23
1999).
24
VerDate Sep 11 2014
23:02 Jan 14, 2019
Jkt 089200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H127.IH
H127
kjohnson on DSK79L0C42 with BILLS
4
•HR 127 IH
(b) LICENSES
FOR MARIJUANA RESEARCH.—Not
1
later than 1 year after the date of enactment of this Act,
2
the Attorney General, acting through the Drug Enforce-
3
ment Administration, shall issue not less than 3 licenses
4
under section 303 of the Controlled Substances Act (21
5
U.S.C. 823) to manufacture and distribute marijuana and
6
marijuana-derivatives for research approved by the Food
7
and Drug Administration.
8
(c) MARIJUANA RESEARCH.—
9
(1) IN GENERAL.—Section 303(f) of the Con-
10
trolled Substances Act (21 U.S.C. 823(f)) is amend-
11
ed—
12
(A)
by
redesignating
paragraphs
(1)
13
through (5) as subparagraphs (A) through (E),
14
respectively;
15
(B) by striking ‘‘(f) The Attorney General’’
16
and inserting ‘‘(f)(1) The Attorney General’’;
17
(C) by striking ‘‘Registration applications’’
18
and inserting the following:
19
‘‘(2) Registration applications’’;
20
(D) in paragraph (2), as so designated, by
21
striking ‘‘schedule I’’ each place that term ap-
22
pears and inserting ‘‘schedule I, except mari-
23
juana,’’;
24
VerDate Sep 11 2014
23:02 Jan 14, 2019
Jkt 089200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H127.IH
H127
kjohnson on DSK79L0C42 with BILLS
5
•HR 127 IH
(E) by striking ‘‘Article 7’’ and inserting
1
the following:
2
‘‘(4) Article 7’’; and
3
(F) by inserting before paragraph (4), as
4
so designated, the following:
5
‘‘(3)(A) Not later than 180 days after the date of
6
enactment of this paragraph, the Secretary shall promul-
7
gate regulations that require the Secretary to register a
8
practitioner to conduct research on marihuana if—
9
‘‘(i) the applicant is authorized to dispense, or
10
conduct research with respect to, controlled sub-
11
stances in schedules II, III, IV, and V under the
12
laws of the State in which the applicant practices;
13
and
14
‘‘(ii) the applicant’s research protocol—
15
‘‘(I) has been reviewed and allowed by—
16
‘‘(aa) the Secretary under section
17
505(i) of the Federal Food, Drug, and
18
Cosmetic Act (21 U.S.C. 355(i)); or
19
‘‘(bb) the National Institutes of
20
Health or another Federal agency that
21
funds scientific research; or
22
‘‘(II) in the case of nonhuman research
23
that is not federally funded, has been volun-
24
VerDate Sep 11 2014
23:02 Jan 14, 2019
Jkt 089200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6201
E:\BILLS\H127.IH
H127
kjohnson on DSK79L0C42 with BILLS
6
•HR 127 IH
tarily submitted by the applicant to, and ap-
1
proved by, the National Institutes of Health.
2
‘‘(B) The Secretary shall grant an application for
3
registration under this paragraph unless the Secretary de-
4
termines that the issuance of the registration would be in-
5
consistent with the public interest. In determining the
6
public interest, the Secretary shall consider the following
7
factors:
8
‘‘(i) The applicant’s experience in dispensing, or
9
conducting research with respect to, controlled sub-
10
stances.
11
‘‘(ii) Compliance with applicable Federal or
12
State laws relating to controlled substances.
13
‘‘(iii) Conduct by the applicant that may threat-
14
en the public health and safety.’’.
15
(2)
CONFORMING
AMENDMENT.—Section
16
102(16) of the Controlled Substances Act (21
17
U.S.C. 802(16)) is amended by inserting ‘‘or ‘mari-
18
juana’ ’’ after ‘‘The term ‘marihuana’ ’’.
19
VerDate Sep 11 2014
23:02 Jan 14, 2019
Jkt 089200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6201
E:\BILLS\H127.IH
H127
kjohnson on DSK79L0C42 with BILLS
7
•HR 127 IH
SEC. 6. PROVISION BY DEPARTMENT OF VETERANS AF-
1
FAIRS HEALTH CARE PROVIDERS OF REC-
2
OMMENDATIONS AND OPINIONS REGARDING
3
VETERAN PARTICIPATION IN STATE MARI-
4
JUANA PROGRAMS.
5
Notwithstanding any other provision of law, the Sec-
6
retary of Veterans Affairs shall authorize physicians and
7
other health care providers employed by the Department
8
of Veterans Affairs to—
9
(1) provide recommendations and opinions to
10
veterans who are residents of States with State
11
marijuana programs regarding the participation of
12
veterans in such State marijuana programs; and
13
(2) complete forms reflecting such recommenda-
14
tions and opinions.
15
Æ
VerDate Sep 11 2014
23:02 Jan 14, 2019
Jkt 089200
PO 00000
Frm 00007
Fmt 6652
Sfmt 6301
E:\BILLS\H127.IH
H127
kjohnson on DSK79L0C42 with BILLS
Important: This plain English summary was generated by AI and is provided for informational purposes only.
It is not legal advice. Always consult the official bill text on Congress.gov
or a qualified attorney for legal matters.